You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023

 

Online download statistics by month:

Online download statistics by month: February 2023 to July 2025

AbstractFullPdf
Feb 202336136475
Mar 2023288294124
Apr 202315916169
May 202322622746
Jun 202313213240
Jul 202310410539
Aug 202316216344
Sep 202310310332
Oct 20239910028
Nov 202313213234
Dec 202311111252
Jan 2024778160
Feb 202415815948
Mar 2024979772
Apr 20249910169
May 2024929542
Jun 2024696839
Jul 202411211445
Aug 2024909032
Sep 20249696608
Oct 2024101101224
Nov 202411511860
Dec 2024959743
Jan 2025848459
Feb 202522922961
Mar 202510210368
Apr 2025909068
May 2025595939
Jun 2025545442
Jul 2025220
Total369837312262